Medical Product Alerts

Read WHO news alert calling for action to protect children from contaminated medicines

Latest WHO Medical Product Alerts:

2024

Alert N°4/2024: Falsified USP/EP PROPYLENE GLYCOL identified in the WHO Eastern Mediterranean Region

Alert N°3/2024: Falsified (contaminated) Oxymorphone Hydrochloride 40mg identified in the WHO Region for Europe

Alert N°2/2024 - Falsified OZEMPIC (semaglutide) identified in the WHO Regions of Americas and Europe

Alert N°1/2024 - Falsified (contaminated) USP/EP PROPYLENE GLYCOL identified in the WHO Eastern Mediterranean Region

2023

Alert N°8/2023 - Substandard (contaminated) syrup and suspension medicines identified in the WHO Regions of the Americas, Eastern Mediterranean, South-East Asia and Western Pacific

Alert N°7/2023 - Falsified DEFITELIO (defibrotide) identified in the WHO Regions of Europe and South-East Asia

Alert N°6/2023 - Substandard (contaminated) syrup medicines identified in WHO Region of the Eastern Mediterranean

Alert N°5/2023 - Substandard (contaminated) syrup medicines identified in WHO Region of Africa

Alert N°4/2023 - Substandard (contaminated) syrup medicines identified in WHO Region of the Western Pacific

Alert N°3/2023 - Falsified DEFITELIO (defibrotide sodium) identified in the WHO Regions of Europe and the Eastern Mediterranean

Alert N°2/2023 - Tetracycline Hydrochloride Ophthalmic Ointment USP 1%

Alert N°1/2023 - Substandard (contaminated) liquid dosage medicines identified in WHO European Region

2022

Alert N°8/2022 - Substandard (contaminated) METHOTREX 50mg CRM:0402908

Alert N°7/2022 - Substandard (contaminated) paediatric liquid dosage medicines identified in WHO region of South-East Asia

Alert N°6/2022 - Substandard (contaminated) paediatric medicines identified in WHO region of Africa

Alert N°5/2022 - Falsified DIPRIVAN (Propofol) identified in WHO region of the Americas

Alert N°4/2022 - the Falsified Dysport identified in the WHO Regions of Europe and Eastern Mediterranean

Alert N°3/2022 - Falsified Intratect (Human normal immunoglobulin) identified in the WHO Regions of the Americas, Eastern Mediterranean and South-East Asia

Alert N°2/2022 - Falsified DESREM (Remdesivir) identified in the WHO Regions of the Americas and South-East Asia

2021

Alert N° 9/2021 - Falsified Soliris identified in WHO regions of the Americas, Europe and South East Asia

Alert N° 8/2021 - Falsified Combiart identified in WHO region of Africa

Alert N° 7/2021 - Falsified COVID-19 VACCINE AstraZeneca identified in WHO region of the Eastern Mediterranean

Alert N° 6/2021 - Falsified Pfizer-BioNTech COVID-19 Vaccine identified in WHO region of the Eastern Mediterranean

Alert N° 5/2021 - Falsified COVISHIELD vaccine identified in the WHO regions of Africa and South- East Asia

Alert N° 4/2021 - Falsified Remdesivir identified in WHO region of the Americas

Alert N° 3/2021 - Falsified CYTOTEC identified in WHO region of Africa

Alert N° 2/2021 - Falsified COVID-19 Vaccine BNT162b2 identified in the WHO region of the Americas

Alert N°1/2021 - Falsified VITAMIN A (retinol) identified in WHO region of Africa

2020

Alert N°7/2020 - Falsified HARVONI (Ledipasvir/sofosbuvir) identified in the WHO regions of the Americas and Europe

Alert N° 6/2020 - Falsified Fluzone® Quadrivalent Influenza Vaccine identified in WHO region of the Americas 

Alert N° 5/2020 - Falsified and contaminated Defibrotide identified in WHO regions of Western Pacific, Europe and Eastern Mediterranean

Alert N°4/2020 - Falsified chloroquine products circulating in the WHO regions of Africa and Europe

Alert N° 3/2020 - Falsified medical products, including in vitro diagnostics, that claim to prevent, detect, treat or cure COVID-19

Alert N° 2/2020 - Falsified HIV rapid diagnostic test circulating in the WHO regions of the Americas and Africa

Alert N°1/2020  -  Falsified antimalarials in Nigeria, Cameroon and Chad

2019

Alert N°11/2019 - Falsified Amoxicillin + Clavulanic Acid products circulating in Haiti

Alert N°10/2019 - Falsified Quinine Bisulphate circulating in Uganda and Quinine Sulphate circulating in Central African Republic and Chad

Alert N°9/2019 - Falsified Augmentin found in Uganda and Kenya 

Alert N° 8/2019 - Falsified Rabies Vaccines and Anti-Rabies Serum circulating in the Philippines

Alert N° 7/2019 - Falsified meglumine antimoniate ampoules in Iran and Pakistan

Alert N°6/2019 - Falsified hydrochlorothiazide (containing glibenclamide) in Cameroon

Alert N°5/2019 - Falsified meningitis vaccines circulating in Niger

Alert N°4/2019 - Falsified oral cholera vaccines circulating in Bangladesh

Alert N° 3/2019 - Falsified ICLUSIG available at patient level in Asia and traded globally

Alert N° 2/2019 - Falsified ICLUSIG traded globally

Alert N° 1/2019  - Falsified Rabies Vaccines circulating in the Philippines

2018

Alert N° 3/2018 - Falsified Hepatitis B Vaccines circulating in Uganda

Alert N° 2/2018 - Falsified “Augmentin” circulating in Cameroon

Alert N° 1/2018 - Falsified cefixime products circulating in the Democratic Republic of the Congo

2017

Alert N° 4/2017 - Falsified Penicillin V circulating in Cameroon

Alert N° 3/2017 - Falsified Avastin (bevacizumab) and Sutent (sunitinib malate) circulating in East Africa

Alert N° 2/2017 - Falsified Quinine Sulphate circulating in Africa

Alert N° 1/2017 - Falsified Meningococcal ACWY Vaccine circulating in West Africa 

2016

Alert N° 4/2016: Quinine Sulphate - Falsified Quinine Sulphate circulating in West and Central Africa

Alert N° 3/2016: LEDSO capsules, DAKAVIR - Falsified Hepatitis C medicines circulating in South East Asia

Alert N° 2/2016: AMARIL - Falsified "AMARIL" yellow fever vaccines circulating in South East Asia

Alert N° 1/2016: Phenobarbitone - Falsified phenobarbitone tablets circulating in West Africa

Find out more about Medical Product Alerts on the WHO website. 

Find out more about organisations combating falsified and substandard medicines.